文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

早期肿瘤退缩与宫颈癌MRI引导放疗最终EBRT反应相关

Early tumor shrinkage correlates with final EBRT response in cervical cancer patients treated with MRI-guided radiotherapy.
PubMed 文献 · Clin Transl Radiat Oncol · 2026-04-06

结果显示第10分次时TVRR与最终反应相关性最强(rho=0.67,p=0.004),且治疗中断显著减慢早期退缩动力学(p=0.003)。

要点

  • 第10分次肿瘤体积缩小率与EBRT结束时的反应强相关(rho=0.67,p=0.004)。
  • 第10分次缩小>50%的患者在EBRT结束时均达到>90%缩小。
  • 治疗中断与早期退缩动力学显著减慢相关(p=0.003)。

核心结论

  • 第10分次前的早期肿瘤缩小与最终EBRT反应强相关,可作为自适应策略的潜在预测标志物。
  • 治疗连续性对初始阶段的理想退缩动力学似乎至关重要。

研究设计与样本

  • 使用400次每日T2加权MRI扫描勾画肿瘤体积,由两名放射肿瘤学家验证。

主要发现

  • 中位肿瘤体积从基线26.2 cc降至第25分次0.7 cc。
  • TVRR与EBRT结束反应的相关性从第5分次rho=0.20(p=0.45)增至第10分次峰值rho=0.67(p=0.004)。
  • 第10分次缩小>50%的所有患者在EBRT结束时均达到>90%缩小。
  • 治疗中断与显著减慢的退缩动力学相关,尤其早期阶段(p=0.003)。

关键数值与推荐

  • 第10分次TVRR与最终EBRT反应的Spearman相关系数rho=0.67(p=0.004)。
  • 第5分次TVRR与最终EBRT反应的Spearman相关系数rho=0.20(p=0.45)。

临床怎么用

  • 可考虑利用MR-Linac每日MRI监测第10分次前的肿瘤体积变化,辅助预测最终放疗反应。
  • 应尽量减少治疗中断,以维持早期肿瘤退缩动力学。

局限性

  • 为回顾性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/PURPOSE: Tumor response can vary significantly in locally advanced cervical cancer patients undergoing radiotherapy. Personalizing treatment based on this variability may improve therapeutic outcomes. This study quantified daily tumor volume evolution on MR-Linac and explored its potential in predicting treatment outcome. MATERIALS/METHODS: Sixteen patients were retrospectively analyzed. Daily T2-weighted MRI scans (n = 400) were used to delineate tumor volumes, validated by two radiation oncologists. Tumor volume reduction rates (TVRR) and regression slopes were assessed across fractions. Spearman analysis evaluated correlations with final external beam radiotherapy (EBRT) response. To assess the impact of treatment interruptions, regression slopes were compared between consecutive (1-day interval) and interrupted delivery (>1 day) across early, middle, and late phases. RESULTS: Median tumor volume decreased from 26.2 cc at baseline to 0.7 cc at fraction 25. TVRR showed progressively stronger associations with end-of-EBRT response, with Spearman coefficients increasing from rho = 0.20 (p = 0.45) at fraction 5 to a peak of rho = 0.67 (p = 0.004) at fraction 10. All patients achieving > 50% reduction by fraction 10 reached > 90% reduction by the end of EBRT. Treatment interruptions were associated with significantly slower regression kinetics, particularly during the early phase (p = 0.003). CONCLUSIONS: Early tumor reduction by fraction 10 is strongly associated with final EBRT response, supporting its role as a potential predictive marker for adaptive strategies. Furthermore, treatment continuity appears critical for optimal regression kinetics in the initial phase. Validation in larger cohorts is needed.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Zidane P, Berger T, Boros A, et al. Early tumor shrinkage correlates with final EBRT response in cervical cancer patients treated with MRI-guided radiotherapy. Clin Transl Radiat Oncol. 2026. PMID: 42005716. doi:10.1016/j.ctro.2026.101158

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。